Global Cannabigerol Market Trends & Growth (2025-2030)

Market Outlook

The Cannabigerol market was valued at USD 693.8 Million in 2024 and is projected to grow to USD 1,752 Million by 2031, with a compound annual growth rate (CAGR) of 14.2% from 2025 to 2030. The Cannabigerol (CBG) market is seeing rapid growth these days, mainly because more people are becoming aware of the potential health benefits it offers, along with its non-psychoactive nature. CBG is often called the "mother" cannabinoid because it serves as a building block for other cannabinoids like THC and CBD. It’s gaining attention for its therapeutic properties, such as reducing inflammation, fighting bacteria, and protecting nerve cells. As a result, there’s a growing demand for CBG-based products, including oils, tinctures, capsules, and topicals, particularly in wellness and medicinal spaces.

The increasing preference for non-psychoactive cannabinoids, combined with ongoing clinical research that is showing promising results for conditions like pain and inflammation, has contributed to the market's expansion. Additionally, the legalization of cannabis in regions like North America and Europe has created a more supportive environment for CBG’s growth. Consumers are also leaning towards natural, plant-based products, which boosts the market further, especially in areas like wellness, skincare, and functional foods.

However, the journey isn’t without its challenges. Regulatory uncertainty is a significant hurdle since the legal landscape surrounding cannabis and its derivatives is constantly changing in many areas. The high production costs—largely due to CBG’s low concentration in cannabis plants—make these products pricier and somewhat less accessible to consumers. Plus, the lack of standardization in product formulations and the lingering stigma around cannabis use can hinder broader acceptance of CBG. While the potential is certainly there, the market still faces limitations due to the need for more comprehensive clinical research to confirm its benefits fully.

Key Insights

North America accounted for the largest share of the Cannabigerol market at 51.53% in 2024. North America is the leading market for Cannabigerol (CBG), largely due to the widespread legalization of cannabis for both medical and recreational use in the U.S. and Canada. The United States, as a major consumer, is seeing increased awareness of CBG’s therapeutic benefits, including its anti-inflammatory and neuroprotective properties. This growth is further supported by extensive research and development in the cannabis industry, with companies actively working on incorporating CBG into wellness, pharmaceutical, and health products. Additionally, the region’s strong regulatory framework and consumer demand for cannabis-based alternatives solidify North America's dominance in the CBG market.

In terms of Type, the Full Spectrum CBG Oil accounted for a major share of 52.80%in 2024. Full Spectrum CBG Oil is a prominent segment in the global cannabigerol (CBG) market due to its extensive benefits. It contains a wide range of cannabinoids, including CBG, CBD, and trace amounts of THC, which work together to create an "entourage effect." This effect enhances the therapeutic potential of the oil. As a result, Full Spectrum CBG Oil has become a popular choice for consumers looking for natural, non-psychoactive solutions for pain relief, anxiety, inflammation, and various other health issues. With the growing demand for plant-based wellness products, the broad-spectrum benefits of Full Spectrum CBG Oil continue to lead the market, attracting those who seek a more balanced therapeutic experience.

Market Dynamics

Drivers:

Consumers are seeking cannabis-based products that provide health benefits without the psychoactive effects of THC.

A growing number of people are using cannabis-based products that claim health advantages without the intoxicating effects of THC (tetrahydrocannabinol). A greater understanding of the medicinal benefits of other cannabinoids, particularly cannabigerol (CBG), is mostly to blame for this change. The fact that CBG is non-psychoactive—that is, it won't alter your thoughts or provide the euphoric effects of THC—makes it an attractive alternative. Because of this, it's a fantastic option for anyone seeking natural solutions without the negative effects associated with typical cannabis use.

People are increasingly looking at ways to manage issues like inflammation, anxiety, and pain while steering clear of the intoxicating effects of THC. This trend is also fueled by the larger wellness movement, where many are becoming more mindful of their health and gravitating toward plant-based, natural treatments. Products infused with CBG and other cannabinoids like CBD are popping up everywhere—think oils, tinctures, topicals, and edibles—thanks to their believed health benefits without compromising day-to-day activities.

As cannabis becomes more legal and accessible in various places, interest in these non-psychoactive compounds is only growing. For those looking to tap into the healing properties of cannabis without the unwanted side effects, CBG is emerging as an attractive option.

The low concentration of CBG in cannabis makes its extraction expensive, limiting affordability and accessibility.

The low concentration of cannabigerol (CBG) in cannabis significantly contributes to the high cost of its extraction, limiting both affordability and accessibility for consumers. CBG is typically found in much lower levels compared to other cannabinoids like THC and CBD, which often necessitates the use of large amounts of raw material to obtain even small quantities of CBG. This results in a more labor-intensive and resource-heavy extraction process, driving up production costs.

Furthermore, CBG is most abundant in cannabis plants that are harvested early in their growth cycle, adding another layer of complexity and expense to its cultivation. Consequently, CBG-based products tend to be more expensive, which can hinder their widespread adoption, especially in price-sensitive regions. To increase CBG accessibility, companies are investing in more efficient extraction methods and developing high-yield cannabis strains. However, the extraction process continues to be a significant barrier to broader market penetration.

Segmental Analysis

Based on Type, Cannabigerol market is segmented into Full Spectrum CBG Oil, THC-free CBG Tincture, CBG Isolate, CBG Softgel Capsules.

The Full Spectrum CBG Oil segment is anticipated to lead the global cannabigerol (CBG) market due to its extensive therapeutic benefits and the increasing consumer preference for natural, holistic health solutions. Full spectrum CBG oil contains a wide variety of cannabinoids, terpenes, and other beneficial compounds found in cannabis plants, which work together in a synergistic manner known as the entourage effect. This effect occurs when the different compounds collaborate to enhance the overall therapeutic efficacy of the product, making it more attractive to consumers seeking improved wellness benefits.

Consumers are increasingly gravitating towards full-spectrum products as they are believed to offer a broader range of health benefits compared to isolates or single-compound products. Full-spectrum CBG oil is commonly used for its potential to reduce inflammation, promote relaxation, and enhance overall well-being. Moreover, the growing trend toward natural and plant-based remedies, along with heightened awareness of the potential health benefits of cannabinoids, has driven demand for full-spectrum CBG oils.

As legal frameworks continue to evolve globally, more markets are becoming open to cannabis-derived products, further boosting the popularity of full-spectrum CBG oil. Its diverse applications in wellness products, including tinctures, topicals, and edibles, also support its dominance in the market. In addition, consumers are becoming more informed about the various benefits of CBG and are increasingly choosing full-spectrum formulations over isolated compounds for a more holistic and effective approach to health.

Regional Landscape

In the context of regional analysis, the Cannabigerol market includes North America, Europe, Asia Pacific, South America, and the Middle East and Africa.

The market size of the North America was valued at USD 358 Million in 2024 and is expected to reach USD 932 Million by 2031, with a CAGR of 14.5% during the forecast period. The North American region is currently the front-runner in the global Cannabigerol (CBG) market, and there are several reasons for this dominance. The United States stands out as the leading market for CBG, largely thanks to its increasingly progressive approach to cannabis legalization. This shift has created a thriving landscape for both recreational and medicinal cannabis use. As more people seek out alternative health solutions, the demand for CBG has surged, particularly because of its promising therapeutic properties like reducing inflammation, anxiety, and providing neuroprotection.

The cannabis industry in North America is not only well-established, but it is also rapidly growing, thanks to changing regulations and a supportive legal environment. In states where cannabis has been legalized for both medical and recreational purposes, this regulatory clarity has spurred considerable investment in research, product development, and distribution, paving the way for innovation and expanding market access.

Moreover, North American consumers are becoming increasingly informed about cannabinoids such as CBG, incorporating them into their daily wellness routines. This heightened awareness, combined with a growing selection of CBG products—ranging from oils and edibles to topical applications—has significantly contributed to the region's strong market presence. With robust distribution networks, advanced manufacturing capabilities, and a high concentration of leading CBG producers, North America is well-positioned to maintain its dominance in the global CBG market for the foreseeable future.

Competitive Landscape

Some of the major companies operating within the Cannabigerol market are: Mile High Labs, GenCanna, ZERO POINT EXTRACTION LLC, Willow Biosciences, Hemptown, Charlottes Web, Canatura, CBDistillery and Others.   

Table of Contents

FAQ (Frequently Asked Questions)